Amsterdam Dementia Cohort: performing research to optimize care

Manuscript Number: 

17-0850R2

Author(s): 
Philip Scheltens, Wiesje M. van der Flier

Disclosures

Philip Scheltens

  • Consulting Fees:
    advisor to Novartis, Genentech, probiodrug, EIP. Payments to institution only.

Wiesje M. van der Flier

  • Lecture Fees:
    Biogen MA Inc
    Grants
    • Agency: 
      Piramal Imaging
      Dates: 
      2014-2018
    • Agency: 
      Boehringer-Ingelheim
      Dates: 
      2013-2015
    • Agency: 
      Biogen MA Inc
      Dates: 
      2017-2018
    • Agency: 
      Roche
      Dates: 
      2017
    • Agency: 
      Janssen-Stellar
      Dates: 
      2015-2017
    • Agency: 
      Combinostics
      Dates: 
      2016